| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.002 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |